Analysis of current status of neoadjuvant chemotherapy for non-small cell lung cancer
10.3760/cma.j.issn.1673-422X.2019.02.011
- VernacularTitle:非小细胞肺癌新辅助化疗的现状分析
- Author:
Qin LI
1
;
Zhenming FU
Author Information
1. 武汉大学人民医院肿瘤科 430060
- Keywords:
Carcinoma,non-small-cell lung;
Chemotherapy,adjuvant
- From:
Journal of International Oncology
2019;46(2):109-112
- CountryChina
- Language:Chinese
-
Abstract:
Lung cancer has been the most dangerous malignant tumor in the worldwide.Nowadays,for patients with resectable early or local advanced non-small cell lung cancer (NSCLC),both domestic and foreign guidelines recommended multidisciplinary treatments like surgery,chemotherapy and radiotherapy.Recent studies have shown that neoadjuvant chemotherapy can significantly improve the prognosis of patients with resectable NSCLC and has better treatment compliance and tolerance.
